# Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients

> **NCT02279264** · — · UNKNOWN · sponsor: **RightBio Metrics** · enrollment: 40 (estimated)

## Conditions studied

- Establish Normative pH Values in Neonates

## Interventions

- **DEVICE:** RightSpot Infant pH Indicator

## Key facts

- **NCT ID:** NCT02279264
- **Lead sponsor:** RightBio Metrics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2014-11
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02279264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02279264, "Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02279264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*